Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV

NCT01535885 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Epstein-Barr Virus Infections
Adenovirus
Cytomegalovirus Infections

Interventions

BIOLOGICAL: Cytotoxic T Lymphocytes

Sponsor

Medical College of Wisconsin